Is There a Role for “Watch and Wait” in Patients With Mantle Cell Lymphoma?-Reference-Cited by-同舟云学术

Is There a Role for “Watch and Wait” in Patients With Mantle Cell Lymphoma?

Published:2011-07 Issue:3 Volume:48 Page:189-193
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Martin Peter,Leonard John

Publisher

Elsevier BV

Subject

Hematology

Reference38 articles.

1. Improvement of overall survival in advanced stage mantle cell lymphoma;Herrmann;J Clin Oncol,2009

2. Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies;Martin;Ann Oncol,2008

3. Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma;Romaguera;Br J Haematol,2010

4. Long-term progression-free survival of mantle cell lymphoma following intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a non-randomized phase-II multicenter study by the Nordic Lymphoma Group;Geisler;Blood,2008

5. Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Management of Mantle Cell Lymphoma With Concurrent Vascular Complications: A Case Report;Cureus;2024-04-04

2. Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma;Journal of Clinical Investigation;2022-02-01

3. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes;Blood;2020-09-17

4. ADCs, BiTEs, CARs, and Small Molecules: A New Era of Targeted Therapy in Non-Hodgkin Lymphoma;American Society of Clinical Oncology Educational Book;2020-05

5. How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation;Hematology, Transfusion and Cell Therapy;2020-04